- Condition: Factory New
-
Learn more:
- MFR: EMED Technologies Ships from MFI Medical
- MPN: SUB-320
Frequently asked questions
Are the materials safe for those with latex allergies?
Yes, this infusion set is completely free of natural rubber latex, making it a safer option for patients with latex sensitivities.
Is the tubing free from harmful chemicals like DEHP?
Absolutely. The infusion set utilizes DEHP-free PVC tubing, ensuring that patients are not exposed to these specific harmful phthalates during their therapy.
How long is the tubing for this set?
The set features 36 inches of flexible, tri-furcated tubing, providing ample length for comfortable movement during subcutaneous immunoglobulin (SCIG) therapy.
What is the priming volume for this device?
The priming volume for the Sub-Q infusion set is 0.65 mL, which is a key technical detail for ensuring accurate dosage delivery.
Does the set include everything needed to secure the site?
Yes, the kit is designed for convenience and includes three site dressings to help you securely and hygienically maintain the infusion sites after insertion.
Is the needle design optimized for patient comfort?
The set features a 27-gauge stainless steel needle with a 9 mm length, engineered specifically to provide consistent and reliable subcutaneous administration.
Does the winged hub help with stabilization?
Yes, the included winged hub is specifically designed to facilitate easy handling and provide better stabilization of the needle during the infusion process.
Is this system suitable for home healthcare use?
While it meets the high standards required for professional clinical environments, it is also perfectly suitable for use in home healthcare settings for patients managing their own SCIG therapy.
Is the needle assembly sterile?
Yes, this is a sterile, non-pyrogenic system manufactured to strict medical standards to ensure patient safety during therapy.
Why is the tri-furcated tubing design beneficial?
The tri-furcated lumen design allows for efficient delivery and flow management, which is essential for the precise administration required during subcutaneous immunoglobulin therapy.